Maravai LifeSciences Inc... (MRVI)
Maravai LifeSciences Statistics
Share Statistics
Maravai LifeSciences has 143.65M shares outstanding. The number of shares has increased by 8.15% in one year.
| Shares Outstanding | 143.65M |
| Shares Change (YoY) | 8.15% |
| Shares Change (QoQ) | 1.27% |
| Owned by Institutions (%) | 99.06% |
| Shares Floating | 116.77M |
| Failed to Deliver (FTD) Shares | 60.3K |
| FTD / Avg. Volume | 1.78% |
Short Selling Information
The latest short interest is 8.82M, so 6.14% of the outstanding shares have been sold short.
| Short Interest | 8.82M |
| Short % of Shares Out | 6.14% |
| Short % of Float | 7.56% |
| Short Ratio (days to cover) | 1.57 |
Valuation Ratios
The PE ratio is -5.19 and the forward PE ratio is -9.13. Maravai LifeSciences's PEG ratio is -0.31.
| PE Ratio | -5.19 |
| Forward PE | -9.13 |
| PS Ratio | 2.9 |
| Forward PS | 1 |
| PB Ratio | 2.31 |
| P/FCF Ratio | -33.87 |
| PEG Ratio | -0.31 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Maravai LifeSciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.11.
| Current Ratio | 7.53 |
| Quick Ratio | 6.65 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | -0.24 |
| Debt / FCF | -1.68 |
| Interest Coverage | -4.94 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $454.71K |
| Profits Per Employee | $-254.12K |
| Employee Count | 570 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | -1.86M |
| Effective Tax Rate | 0.71% |
Stock Price Statistics
The stock price has increased by -78.62% in the last 52 weeks. The beta is 0.18, so Maravai LifeSciences's price volatility has been higher than the market average.
| Beta | 0.18 |
| 52-Week Price Change | -78.62% |
| 50-Day Moving Average | 3.02 |
| 200-Day Moving Average | 6.18 |
| Relative Strength Index (RSI) | 27.13 |
| Average Volume (20 Days) | 3.4M |
Income Statement
In the last 12 months, Maravai LifeSciences had revenue of 259.19M and earned -144.85M in profits. Earnings per share was -1.05.
| Revenue | 259.19M |
| Gross Profit | 108.31M |
| Operating Income | -235.62M |
| Net Income | -144.85M |
| EBITDA | -156.92M |
| EBIT | -213.78M |
| Earnings Per Share (EPS) | -1.05 |
Balance Sheet
The company has 322.4M in cash and 37.34M in debt, giving a net cash position of 285.06M.
| Cash & Cash Equivalents | 322.4M |
| Total Debt | 37.34M |
| Net Cash | 285.06M |
| Retained Earnings | 140.89M |
| Total Assets | 1.01B |
| Working Capital | 372.18M |
Cash Flow
In the last 12 months, operating cash flow was 7.46M and capital expenditures -29.66M, giving a free cash flow of -22.19M.
| Operating Cash Flow | 7.46M |
| Capital Expenditures | -29.66M |
| Free Cash Flow | -22.19M |
| FCF Per Share | -0.16 |
Margins
Gross margin is 41.79%, with operating and profit margins of -90.91% and -55.89%.
| Gross Margin | 41.79% |
| Operating Margin | -90.91% |
| Pretax Margin | -100.89% |
| Profit Margin | -55.89% |
| EBITDA Margin | -60.54% |
| EBIT Margin | -90.91% |
| FCF Margin | -8.56% |
Dividends & Yields
MRVI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MRVI is $5, which is 187.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $5 |
| Price Target Difference | 187.4% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 0.55 |
| Piotroski F-Score | 4 |